Lucem Health Launches Reveal for Lung Cancer, A New AI-Driven Solution to Accelerate Lung Cancer Screening for At-Risk Patients
DAVIDSON, N.C., May 2, 2024 /PRNewswire/ -- Lucem Health™, a leader in AI-driven early disease detection solutions, announced today the introduction of Reveal for Lung Cancer. This innovative new solution aims to help healthcare organizations improve the identification and engagement of patients at a higher statistical risk for certain respiratory illnesses, including cancers of the lung or trachea, facilitating earlier diagnosis and treatment.
- "Reveal for Lung Cancer provides an effective new solution for addressing the deadliest cancer worldwide," Sean Cassidy.
- Lung cancer remains the leading cause of cancer death in the United States and the third most common cancer diagnosis.
- By using Reveal for Lung Cancer for two years, a provider organization can expect to identify about 60% more patients with early-stage lung cancer.
- "Reveal for Lung Cancer provides an effective new solution for addressing the deadliest cancer worldwide," says Sean Cassidy, CEO of Lucem Health.